Johnson & Johnson (NYSE: JNJ) will sell its entire stake of more than 18.3 million shares of Achillion Pharmaceuticals Inc. (Nasdaq: ACHN). Shares of Johnson & Johnson lost 39 cents to close at $139.10 while Achillion Pharmaceuticals stock dropped 66 cents to close at $3.03.
Johnson & Johnson sells stake in Achillion Pharmaceuticals
November 15, 2017 at 17:42 PM EST
